Myasthenia Gravis Inebilizumab Trial

Clinical trial NCT04524273 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04524273
Sponsor: Amgen
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Myasthenia Gravis

Start date: 2020-10-15
Primary completion: 2024-05-28
Enrollment: 238

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.